Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Audistim is a multi-ingredient dietary supplement, primarily marketed as Audistim Day/Night, designed to manage chronic tinnitus and its associated impact on quality of life, sleep, and stress. The formulation is based on a multifactorial approach to tinnitus pathophysiology, incorporating ingredients that target the auditory system, microcirculation, and psychological factors. The "Day" formula typically contains Ginkgo biloba, magnesium, and B-vitamins (B3, B6, B12) to support nerve function and blood flow. The "Night" formula includes melatonin, zinc, and California poppy (Eschscholzia californica) to improve sleep quality and reduce nighttime tinnitus perception. Clinical evidence from randomized controlled trials suggests that Audistim significantly reduces the Tinnitus Handicap Inventory (THI) score, particularly in patients with permanent tinnitus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Audistim.